| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tas-119 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pentalogy of Cantrell[MeSHID:D058502] |
2.55 | phase 1 | unknown |
| tas-119 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Pentalogy of Cantrell[MeSHID:D058502] |
2.55 | phase 1 | inhibitor |
| click here to return to the previous page | ||||||||